Chimeric glycosaminoglycan oligosaccharides synthesized by enzymatic reconstruction and their use in substrate specificity determination of Streptococcus hyaluronidase
K. Takagaki et al., Chimeric glycosaminoglycan oligosaccharides synthesized by enzymatic reconstruction and their use in substrate specificity determination of Streptococcus hyaluronidase, J BIOCHEM, 127(4), 2000, pp. 695-702
A method was developed for the reconstruction of glycosaminoglycan (GAG) ol
igosaccharides using the transglycosylation reaction of an endo-beta-N-acet
ylhexosaminidase, testicular hyaluronidase, under optimal conditions. Repet
ition of the transglycosylation using suitable combinations of various GAGs
as accepters and donors made it possible to custom-synthesize GAG oligosac
charides. Thus we prepared a library of chimeric GAG; oligosaccharides with
hybrid structures composed of disaccharide units such as GlcA-GlcNAc (from
hyaluronic acid), GlcA-GalNAc (from chondroitin), GlcA-GalNAc4S (from chon
droitin 4-sulfate), GlcA-GalNAc6S (from chondroitin g-sulfate), IdoA-GalNAc
(from desulfated dermatan sulfate), and GlcA-GalNAc4,6-diS (from chondroit
in sulfate E). The specificity of the hyaluronidase from Streptococcus dysg
alactiae (hyaluronidase SD) was then investigated using these chimeric GAG
oligosaccharides as model substrates. The results indicate that the specifi
city of hyaluronidase SD is determined by the following restrictions at the
nonreducing terminal side of the cleavage site: (i) at least one disacchar
ide unit (GlcA-GlcNAc) is necessary for the enzymatic action of hyaluronida
se SD; (ii) cleavage is inhibited by sulfation of the N-acetylgalactosamine
; (iii) hyaluronidase SD releases GlcA-GalNAc and IdoA-GalNAc units as well
as GlcA-GlcNAc, At the reducing terminal side of the cleavage site, the su
lfated residues on the N-acetylgalactosamines in the disaccharide units wer
e found to have no influence on the cleavage. Additionally, we found that h
yaluronidase SD can specifically and endolytically cleave the internal unsu
lfated regions of chondroitin sulfate chains. This demonstration indicates
that custom-synthesized GAG; oligosaccharides will open a new avenue in GAG
; glycotechnology.